查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1487587

眼部药物传递技术市场（技术：局部、眼部插入、离子电渗透疗法、眼内植入、原位凝胶和泪点塞等）- 全球产业分析、规模、份额、成长、趋势和预测， 2024-2034 年

Ocular Drug Delivery Technology Market (Technology: Topical, Ocular Insert, Iontophoresis, Intraocular Implant, In Situ Gel & Punctal Plug, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 214 Pages | 商品交期: 2-10个工作天内

价格

眼部给药技术市场 - 报告范围

TMR 关于全球眼部药物输送技术市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 2034 年交付技术市场，以2024 年为基准年，2034 年为预测年。报告中也提供了2024年至2034年全球眼部给药技术市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解眼部药物传输技术市场。

市场概况
2023年市场价值 163 亿美元
2034 年市场价值 302 亿美元
复合年增长率 5.7%

该报告深入探讨了全球眼部给药技术市场的竞争格局。全球眼部药物输送技术市场的主要参与者已经确定，并对每个参与者的各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球眼部药物输送技术市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依技术分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依技术分类，2020-2034
    • 专题
    • 眼插入物
      • 易蚀的
      • 不易腐蚀
    • 离子电渗透疗法
    • 眼内植入物
      • 可生物降解
      • 非生物分解
    • 原位凝胶和泪点塞
    • 其他的
  • 市场吸引力：依技术分类

第 7 章：全球市场分析与预测：依配方类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依配方类型，2020-2034年
    • 解决方案
    • 暂停
    • 乳液
    • 脂质体和奈米颗粒
    • 软膏
  • 市场吸引力：按配方类型

第 8 章：全球市场分析与预测：按疾病类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依疾病类型，2020-2034
    • 青光眼
    • 黄斑部病变
    • 糖尿病性视网膜病变
    • 白内障
    • 糖尿病黄斑水肿
    • 干眼症
    • 其他的
  • 市场吸引力：按疾病类型

第 9 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2020-2034
    • 医院
    • 门诊手术中心
    • 眼科诊所
    • 家庭护理设置
  • 市场吸引力：按最终用户划分

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2034
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司分类（2023）
  • 公司简介
    • Ocular Therapeutix, Inc.
    • Alimera Sciences Inc.
    • Allergan (an AbbVie company)
    • Bausch Health Companies Inc.
    • EyeGate Pharmaceuticals, Inc.
    • Envisia Therapeutics Inc.
    • Clearside Biomedical, Inc.
    • Graybug Vision, Inc.
    • Santen Pharmaceutical Co., Ltd.
    • Taiwan Liposome Company, Ltd.
Product Code: TMRGL2869

Ocular Drug Delivery Technology Market - Scope of Report

TMR's report on the global ocular drug delivery technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global ocular drug delivery technology market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ocular drug delivery technology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ocular drug delivery technology market.

Market Snapshot
Market Value in 2023US$ 16.3 Bn
Market Value in 2034US$ 30.2 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global ocular drug delivery technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global ocular drug delivery technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global ocular drug delivery technology market.

The report delves into the competitive landscape of the global ocular drug delivery technology market. Key players operating in the global ocular drug delivery technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global ocular drug delivery technology market profiled in this report.

Key Questions Answered in Global ocular drug delivery technology Market Report:

  • What is the sales/revenue generated by ocular drug delivery technology across all regions during the forecast period?
  • What are the opportunities in the global ocular drug delivery technology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Ocular Drug Delivery Technology Market - Research Objectives and Research Approach

The comprehensive report on the global ocular drug delivery technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global ocular drug delivery technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global ocular drug delivery technology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ocular Drug Delivery Technology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Ocular Drug Delivery Technology Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Technology

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Technology, 2020-2034
    • 6.3.1. Topical
    • 6.3.2. Ocular Insert
      • 6.3.2.1. Erodible
      • 6.3.2.2. Non-erodible
    • 6.3.3. Iontophoresis
    • 6.3.4. Intraocular Implant
      • 6.3.4.1. Biodegradable
      • 6.3.4.2. Non-biodegradable
    • 6.3.5. In Situ Gel & Punctal Plug
    • 6.3.6. Others
  • 6.4. Market Attractiveness, by Technology

7. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Formulation Type

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Formulation Type, 2020-2034
    • 7.3.1. Solution
    • 7.3.2. Suspension
    • 7.3.3. Emulsion
    • 7.3.4. Liposome & Nanoparticle
    • 7.3.5. Ointment
  • 7.4. Market Attractiveness, by Formulation Type

8. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Disease Type

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Disease Type, 2020-2034
    • 8.3.1. Glaucoma
    • 8.3.2. Macular Degeneration
    • 8.3.3. Diabetic Retinopathy
    • 8.3.4. Cataract
    • 8.3.5. Diabetic Macular Edema
    • 8.3.6. Dry Eye Syndrome
    • 8.3.7. Others
  • 8.4. Market Attractiveness, by Disease Type

9. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2034
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Ophthalmic Clinics
    • 9.3.4. Homecare Settings
  • 9.4. Market Attractiveness, by End-user

10. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Ocular Drug Delivery Technology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Technology, 2020-2034
    • 11.2.1. Topical
    • 11.2.2. Ocular Insert
      • 11.2.2.1. Erodible
      • 11.2.2.2. Non-erodible
    • 11.2.3. Iontophoresis
    • 11.2.4. Intraocular Implant
      • 11.2.4.1. Biodegradable
      • 11.2.4.2. Non-biodegradable
    • 11.2.5. In Situ Gel & Punctal Plug
    • 11.2.6. Others
  • 11.3. Market Attractiveness, by Technology
  • 11.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 11.4.1. Solution
    • 11.4.2. Suspension
    • 11.4.3. Emulsion
    • 11.4.4. Liposome & Nanoparticle
    • 11.4.5. Ointment
  • 11.5. Market Attractiveness, by Formulation Type
  • 11.6. Market Value Forecast, by Disease Type, 2020-2034
    • 11.6.1. Glaucoma
    • 11.6.2. Macular Degeneration
    • 11.6.3. Diabetic Retinopathy
    • 11.6.4. Cataract
    • 11.6.5. Diabetic Macular Edema
    • 11.6.6. Dry Eye Syndrome
    • 11.6.7. Others
  • 11.7. Market Attractiveness, by Disease Type
  • 11.8. Market Value Forecast, by End-user, 2020-2034
    • 11.8.1. Hospitals
    • 11.8.2. Ambulatory Surgical Centers
    • 11.8.3. Ophthalmic Clinics
    • 11.8.4. Homecare Settings
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Technology
    • 11.11.2. By Formulation Type
    • 11.11.3. By Disease Type
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Ocular Drug Delivery Technology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Technology, 2020-2034
    • 12.2.1. Topical
    • 12.2.2. Ocular Insert
      • 12.2.2.1. Erodible
      • 12.2.2.2. Non-erodible
    • 12.2.3. Iontophoresis
    • 12.2.4. Intraocular Implant
      • 12.2.4.1. Biodegradable
      • 12.2.4.2. Non-biodegradable
    • 12.2.5. In Situ Gel & Punctal Plug
    • 12.2.6. Others
  • 12.3. Market Attractiveness, by Technology
  • 12.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 12.4.1. Solution
    • 12.4.2. Suspension
    • 12.4.3. Emulsion
    • 12.4.4. Liposome & Nanoparticle
    • 12.4.5. Ointment
  • 12.5. Market Attractiveness, by Formulation Type
  • 12.6. Market Value Forecast, by Disease Type, 2020-2034
    • 12.6.1. Glaucoma
    • 12.6.2. Macular Degeneration
    • 12.6.3. Diabetic Retinopathy
    • 12.6.4. Cataract
    • 12.6.5. Diabetic Macular Edema
    • 12.6.6. Dry Eye Syndrome
    • 12.6.7. Others
  • 12.7. Market Attractiveness, by Disease Type
  • 12.8. Market Value Forecast, by End-user, 2020-2034
    • 12.8.1. Hospitals
    • 12.8.2. Ambulatory Surgical Centers
    • 12.8.3. Ophthalmic Clinics
    • 12.8.4. Homecare Settings
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Technology
    • 12.11.2. By Formulation Type
    • 12.11.3. By Disease Type
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Ocular Drug Delivery Technology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Technology, 2020-2034
    • 13.2.1. Topical
    • 13.2.2. Ocular Insert
      • 13.2.2.1. Erodible
      • 13.2.2.2. Non-erodible
    • 13.2.3. Iontophoresis
    • 13.2.4. Intraocular Implant
      • 13.2.4.1. Biodegradable
      • 13.2.4.2. Non-biodegradable
    • 13.2.5. In Situ Gel & Punctal Plug
    • 13.2.6. Others
  • 13.3. Market Attractiveness, by Technology
  • 13.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 13.4.1. Solution
    • 13.4.2. Suspension
    • 13.4.3. Emulsion
    • 13.4.4. Liposome & Nanoparticle
    • 13.4.5. Ointment
  • 13.5. Market Attractiveness, by Formulation Type
  • 13.6. Market Value Forecast, by Disease Type, 2020-2034
    • 13.6.1. Glaucoma
    • 13.6.2. Macular Degeneration
    • 13.6.3. Diabetic Retinopathy
    • 13.6.4. Cataract
    • 13.6.5. Diabetic Macular Edema
    • 13.6.6. Dry Eye Syndrome
    • 13.6.7. Others
  • 13.7. Market Attractiveness, by Disease Type
  • 13.8. Market Value Forecast, by End-user, 2020-2034
    • 13.8.1. Hospitals
    • 13.8.2. Ambulatory Surgical Centers
    • 13.8.3. Ophthalmic Clinics
    • 13.8.4. Homecare Settings
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Technology
    • 13.11.2. By Formulation Type
    • 13.11.3. By Disease Type
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Ocular Drug Delivery Technology Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Technology, 2020-2034
    • 14.2.1. Topical
    • 14.2.2. Ocular Insert
      • 14.2.2.1. Erodible
      • 14.2.2.2. Non-erodible
    • 14.2.3. Iontophoresis
    • 14.2.4. Intraocular Implant
      • 14.2.4.1. Biodegradable
      • 14.2.4.2. Non-biodegradable
    • 14.2.5. In Situ Gel & Punctal Plug
    • 14.2.6. Others
  • 14.3. Market Attractiveness, by Technology
  • 14.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 14.4.1. Solution
    • 14.4.2. Suspension
    • 14.4.3. Emulsion
    • 14.4.4. Liposome & Nanoparticle
    • 14.4.5. Ointment
  • 14.5. Market Attractiveness, by Formulation Type
  • 14.6. Market Value Forecast, by Disease Type, 2020-2034
    • 14.6.1. Glaucoma
    • 14.6.2. Macular Degeneration
    • 14.6.3. Diabetic Retinopathy
    • 14.6.4. Cataract
    • 14.6.5. Diabetic Macular Edema
    • 14.6.6. Dry Eye Syndrome
    • 14.6.7. Others
  • 14.7. Market Attractiveness, by Disease Type
  • 14.8. Market Value Forecast, by End-user, 2020-2034
    • 14.8.1. Hospitals
    • 14.8.2. Ambulatory Surgical Centers
    • 14.8.3. Ophthalmic Clinics
    • 14.8.4. Homecare Settings
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Technology
    • 14.11.2. By Formulation Type
    • 14.11.3. By Disease Type
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Ocular Drug Delivery Technology Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Technology, 2020-2034
    • 15.2.1. Topical
    • 15.2.2. Ocular Insert
      • 15.2.2.1. Erodible
      • 15.2.2.2. Non-erodible
    • 15.2.3. Iontophoresis
    • 15.2.4. Intraocular Implant
      • 15.2.4.1. Biodegradable
      • 15.2.4.2. Non-biodegradable
    • 15.2.5. In Situ Gel & Punctal Plug
    • 15.2.6. Others
  • 15.3. Market Attractiveness, by Technology
  • 15.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 15.4.1. Solution
    • 15.4.2. Suspension
    • 15.4.3. Emulsion
    • 15.4.4. Liposome & Nanoparticle
    • 15.4.5. Ointment
  • 15.5. Market Attractiveness, by Formulation Type
  • 15.6. Market Value Forecast, by Disease Type, 2020-2034
    • 15.6.1. Glaucoma
    • 15.6.2. Macular Degeneration
    • 15.6.3. Diabetic Retinopathy
    • 15.6.4. Cataract
    • 15.6.5. Diabetic Macular Edema
    • 15.6.6. Dry Eye Syndrome
    • 15.6.7. Others
  • 15.7. Market Attractiveness, by Disease Type
  • 15.8. Market Value Forecast, by End-user, 2020-2034
    • 15.8.1. Hospitals
    • 15.8.2. Ambulatory Surgical Centers
    • 15.8.3. Ophthalmic Clinics
    • 15.8.4. Homecare Settings
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Technology
    • 15.11.2. By Formulation Type
    • 15.11.3. By Disease Type
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Ocular Therapeutix, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Alimera Sciences Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Allergan (an AbbVie company)
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Bausch Health Companies Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. EyeGate Pharmaceuticals, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Envisia Therapeutics Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Clearside Biomedical, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Graybug Vision, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Santen Pharmaceutical Co., Ltd.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Taiwan Liposome Company, Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 02: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 03: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 04: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 05: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 08: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 09: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 10: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 11: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 13: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 14: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 15: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 18: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 19: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 20: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 23: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 24: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 25: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 28: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 29: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 30: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn), by Region, 2023 and 2034
  • Figure 02: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by Technology, 2023
  • Figure 03: Global Ocular Drug Delivery Technology Market Value Share, by Technology, 2023
  • Figure 04: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by Formulation Type, 2023
  • Figure 05: Global Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2023
  • Figure 06: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by Disease Type, 2023
  • Figure 07: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2023
  • Figure 08: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by End-user, 2023
  • Figure 09: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2023
  • Figure 10: Global Ocular Drug Delivery Technology Market Value Share, by Region, 2023
  • Figure 11: Global Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 12: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 13: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 14: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 15: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 16: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 17: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 18: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by End-user, 2023
  • Figure 19: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2023
  • Figure 20: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 21: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 22: North America Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 23: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 25: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 26: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 27: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 28: North America Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 29: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 30: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 31: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 32: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 34: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 35: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 37: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 38: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 39: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 40: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 41: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 42: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 43: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 45: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 46: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 47: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 48: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 49: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 50: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 52: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 53: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 54: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 55: Latin America Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 56: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 57: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 59: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 60: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 61: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 62: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 63: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 64: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 65: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 69: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 70: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 71: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 72: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 74: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 75: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 76: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034